Portal Hypertension Completed Phase 1 / 2 Trials for Octreotide (DB00104)
Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029015 (Portal Hypertension) | Completed | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01188733 | Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis | Prevention |